Literature DB >> 16471470

Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE.

Wataru Fujimoto1, Toshihisa Hamada, Jun Yamada, Hironori Matsuura, Keiji Iwatsuki.   

Abstract

Bullous systemic lupus erythematosus (BSLE) is a rare subset of systemic lupus erythematosus that is often associated with autoimmunity to type VII collagen. We describe a 45-year-old woman with BSLE who presented with vesiculobullous lesions as an initial manifestation of SLE. The patient first noticed a widespread urticarial, erythematous eruption associated with tense blisters, erosions, and crusting. She was diagnosed with bullous pemphigoid and underwent a one-month course of treatment with betamethazone. Because of the appearance of marked proteinuria, a subsequent renal biopsy, and serological tests, the patient was diagnosed with rapidly progressive glomerulonephritis and systemic lupus erythematosus. The patient's IgG circulating antibodies labeled the dermal floor of salt-split skin and recognized type VII collagen in immunoblot studies. Although methylprednisolone pulse therapy for glomerulonephritis did not alleviate the vesicullobullous eruption, treatment with dapsone resulted in dramatic disappearance of the lesions. Cessation of dapsone therapy due to hemolysis with Heinz-body formation did not aggravate the bullous disease. Our case illustrates that a generalized vesiculobullous eruption can be the sole presenting manifestation of SLE. It also emphasizes the close temporal relationship between BSLE and lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16471470     DOI: 10.1111/j.1346-8138.2005.tb00894.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  13 in total

Review 1.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Bullous Systemic Lupus Erythematosus and Lupus Nephritis in a Young Girl.

Authors:  Tooba Momen; Yahya Madihi
Journal:  Oman Med J       Date:  2016-11

Review 3.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

4.  Bullous lesions as a manifestation of systemic lupus erythematosus in two Mexican teenagers.

Authors:  Marimar Sáez-de-Ocariz; Francisco Espinosa-Rosales; Eduardo López-Corella; Beatriz de León-Bojorge
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

Review 5.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Immunol Allergy Clin North Am       Date:  2012-04-18       Impact factor: 3.479

Review 6.  Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature.

Authors:  Direkrit Chiewchengchol; Ruth Murphy; Steven W Edwards; Michael W Beresford
Journal:  Pediatr Rheumatol Online J       Date:  2015-01-05       Impact factor: 3.054

7.  Diffuse Bullous Eruptions in an Elderly Woman: Late-Onset Bullous Systemic Lupus Erythematosus.

Authors:  Prajwal Boddu; Mojtaba Nadiri; Owais Malik
Journal:  Case Rep Dermatol       Date:  2016-10-13

Review 8.  Oral Ulcers in Juvenile-Onset Systemic Lupus Erythematosus: A Review of the Literature.

Authors:  Pongsawat Rodsaward; Titipong Prueksrisakul; Tawatchai Deekajorndech; Steven W Edwards; Michael W Beresford; Direkrit Chiewchengchol
Journal:  Am J Clin Dermatol       Date:  2017-12       Impact factor: 7.403

9.  Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.

Authors:  Maria Cristina Maggio; Giovanni Corsello; Eugenia Prinzi; Rolando Cimaz
Journal:  Am J Case Rep       Date:  2017-03-29

10.  Unusual presentation of childhood Systemic Lupus Erythematosus.

Authors:  Sathish Kumar; Indira Agarwal
Journal:  Pediatr Rheumatol Online J       Date:  2007-11-21       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.